Investigational drug · Phase 3
DEH113
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Primary Dysmenorrhea.
Phase 3Last checked: Nov 19, 2026Latest source record: Feb 22, 2024 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
2
Any phase or sponsor naming "DEH113"
First trial start
2025
Feb 2025
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
- EMS1
All registered trials by phase
Every ClinicalTrials.gov drug study naming "DEH113", any sponsor or status.
Conditions studied
As listed on its trial records.
- Primary Dysmenorrhea
Largest trials
Live from ClinicalTrials.gov: studies naming "DEH113" as an intervention, largest first.
- Efficacy and Safety of DEH113 in the Treatment of Menstrual Cramp Pain Associated With Primary DysmenorrheaPivotal-lookingNot yet recruiting
EMSIndustry
NCT06268054 · 78 participants (planned) · Start Feb 2025 · Primary completion Feb 2027
Drug: DEH113; Placebo Comparator · For: Primary Dysmenorrhea
- Efficacy and Safety of DEH113 in the Treatment of Menstrual Cramp Pain in Primary Dysmenorrhea: a Pilot StudyStatus unknown
EMSIndustry
NCT06555549 · 60 participants (planned) · Start Sep 2024 · Primary completion Sep 2025
Drug: DEH113; Placebo · For: Primary Dysmenorrhea
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Primary Dysmenorrhea
- DLBS1442DismenoPhase 31 trial
Dexa Medica Group · Primary Dysmenorrhea
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.